📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

The EGFR/ErbB inhibitor neratinib modifies the neutrophil phosphoproteome and promotes apoptosis and clearance by airway macrophages. (2022)

First Author: Herman KD

Attributed to: MICA: Finding new treatments for failed resolution of inflammation using zebrafish models. funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3389/fimmu.2022.956991

PubMed Identifier: 35967296

Publication URI: http://europepmc.org/abstract/MED/35967296

Type: Journal Article/Review

Volume: 13

Parent Publication: Frontiers in immunology

ISSN: 1664-3224